CSIMarket
 


Organon and Co   (OGN)
Other Ticker:  
 


Organon And Co 's EBITDA Margin by quarter

Trends, Rankings, Statistics



OGN EBITDA Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 7.61 % -1.17 % 1.45 % -1.85 % -7.36 %
Seq. Revenue Change 5.2 % -5.53 % 4.55 % 3.57 % -3.38 %
Revenue In Millions $1,598.00 $1,519.00 $1,608.00 $1,538.00 $1,485.00
EBITDA Margin 18.34 % 18.1 % 27.61 % 27.57 % 25.52 %
EBITDA Margin Total Ranking # 1086 # 1600 # 1163 # 1149 # 1475
EBITDA In Millions $293.00 $275.00 $444.00 $424.00 $379.00
Y / Y EBITDA Change -22.69 % -38.48 % 2.07 % -14.34 % 27.18 %
Seq. EBITDA Change 6.55 % -38.06 % 4.72 % 11.87 % -15.21 %


Commenting fourth Quarter 2023 EBITDA Margin
Organon and Co EBITDA grew by 6.55 % in IV. Quarter sequentially to 293 millions, while Revenue increased by 5.2 %, this led to improvement in the company's EBITDA Margin to 18.34 %, EBITDA Margin remained below Organon and Co average.

Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 28 other companies have achieved higher EBITDA Margin. While EBITDA Margin total ranking has impoved so far to 1086, from total ranking in previous quarter at 1600.
Learn about Operating Margin
OGN's EBITDA Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 29
Healthcare Sector # 89
Overall # 1086

EBITDA Margin Statistics
High Average Low
33.53 % 26.25 % 18.1 %
(Mar 31 2021)   (Sep 30 2023)




Other EBITDA Margin Profitability Ratios
OGN's Cumulative EBITDA Margin
Major Pharmaceutical Preparations Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
OGN's EBITDA Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for OGN's Competitors
EBITDA Margin Profit Margin for Organon And Co 's Suppliers
EBITDA Margin Profit Margin for OGN's Customers

You may also want to know
OGN's Annual Growth Rates OGN's Profitability Ratios OGN's Asset Turnover Ratio OGN's Dividend Growth
OGN's Roe OGN's Valuation Ratios OGN's Financial Strength Ratios OGN's EBITDA Growth
OGN's Roa OGN's Inventory Turnover Ratio OGN's Growth Rates OGN's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry EBITDA MarginDec 31 2023 MRQ EBITDADec 31 2023 MRQ Revenue
Vertex Pharmaceuticals Inc  47.50 %$ 1,196.000 $ 2,517.700 
Protagonist Therapeutics inc   45.97 %$ 27.583 $ 60.000 
Johnson and Johnson  41.99 %$ 5,682.000 $ 13,532.000 
Zoetis Inc   37.73 %$ 835.000 $ 2,213.000 
Regeneron Pharmaceuticals Inc   37.24 %$ 1,278.900 $ 3,434.300 
Harmony Biosciences Holdings inc   36.35 %$ 61.244 $ 168.472 
Bristol myers Squibb Company  36.05 %$ 4,138.000 $ 11,477.000 
Ironwood Pharmaceuticals inc   33.93 %$ 39.882 $ 117.553 
Eli Lilly And Company  30.97 %$ 2,896.500 $ 9,353.400 
Bausch Health Companies Inc   29.03 %$ 699.000 $ 2,408.000 
Jazz Pharmaceuticals Plc  28.76 %$ 291.051 $ 1,011.935 
Corcept Therapeutics Inc  27.61 %$ 37.380 $ 135.405 
Abbott Laboratories  27.02 %$ 2,767.000 $ 10,241.000 
Abbvie inc   25.63 %$ 3,666.000 $ 14,301.000 
Xeris Biopharma Holdings Inc   22.45 %$ 9.967 $ 44.390 
Novartis Ag  20.20 %$ 9,427.000 $ 46,660.000 
Alpine Immune Sciences Inc   20.13 %$ 6.211 $ 30.853 
Organon and Co   18.34 %$ 293.000 $ 1,598.000 
Ani Pharmaceuticals Inc  17.35 %$ 22.839 $ 131.654 
Teva Pharmaceutical Industries Limited  16.58 %$ 739.000 $ 4,456.000 
Alimera Sciences Inc   16.09 %$ 4.288 $ 26.652 
Aytu Biopharma Inc   13.25 %$ 2.941 $ 22.203 
Amneal Pharmaceuticals Inc   12.30 %$ 76.015 $ 617.827 
Elanco Animal Health Inc  10.72 %$ 111.000 $ 1,035.000 
Nature s Sunshine Products inc   9.75 %$ 10.783 $ 110.631 
Earth Science Tech Inc   8.51 %$ 0.287 $ 3.377 
Ionis Pharmaceuticals Inc  8.50 %$ 32.243 $ 379.125 
Biomarin Pharmaceutical Inc  8.24 %$ 53.276 $ 646.207 
Phibro Animal Health Corporation  6.97 %$ 17.394 $ 249.616 
Perrigo Company Plc  6.45 %$ 74.700 $ 1,158.400 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com